by Eneida R. Nemecek
Explore ASTCT’s Board Member Spotlight featuring Dr. Eneida Nemecek, a leader in pediatric blood and marrow transplantation and cellular therapy at OHSU. She shares insights on her clinical...
by ASTCT Talks
In a cobranded episode between Oncology on the Go, hosted by CancerNetwork®, and the American Society for Transplantation and Cellular Therapy (ASTCT)’s program ASTCT Talks,...
by ASTCT Talks
In this episode of ASTCT Talks, host Dr. Corey Cutler, MD, from Dana-Farber Cancer Institute, is joined by Dr. Pooja Khandelwal, MD (Cincinnati Children’s Hospital), Dr. Ben...
by Bone Marrow Transplantation
Researchers describe a novel reduced-intensity conditioning protocol that could potentially resolve a common treatment barrier for adults with sickle cell disease (SCD). Children with SCD...
by Blood Advances
The best timeline for SARS-CoV-2 immunization after undergoing cellular therapy is not known, but recent findings indicate that mRNA SARS-CoV-2 vaccination within 4 months does not appear to...
by Blood
An understanding of extended HLA haplotypes can help narrow down the best choice of haploidentical donor for hematopoietic cell transplantation (HCT), according to results from a multivariable...